PER OLOF
ANDERSON
PROF. AYUDANTE DOCTOR
![Foto de PER OLOF](/img/nophoto.png)
![Foto de Instituto de Parasitología y Biomedicina López Neyra](/img/noimage_org.png)
Instituto de Parasitología y Biomedicina López Neyra
Armilla, EspañaInstituto de Parasitología y Biomedicina López Neyra -ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2017
2013
-
Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis
Gut, Vol. 62, Núm. 8, pp. 1131-1141
2010
-
Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757
International Immunopharmacology, Vol. 10, Núm. 8, pp. 837-842
-
Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels
Molecular and Cellular Biology, Vol. 30, Núm. 10, pp. 2537-2551
2009
-
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
Gut, Vol. 58, Núm. 7, pp. 929-939
-
Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide
Journal of Immunology, Vol. 183, Núm. 7, pp. 4346-4359
-
Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death
Cell Death and Differentiation, Vol. 16, Núm. 3, pp. 406-416
2008
-
Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: A new therapeutic approach for immune disorders
Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 5B, pp. 1830-1847
-
Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria
Journal of Immunology, Vol. 180, Núm. 12, pp. 8369-8377
2007
-
Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy
Annals of the Rheumatic Diseases
-
Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders
Peptides, Vol. 28, Núm. 9, pp. 1833-1846